BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10571413)

  • 21. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor.
    Sengupta S; Gherardi E; Sellers LA; Wood JM; Sasisekharan R; Fan TP
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):69-75. PubMed ID: 12524227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.
    Zhang YW; Su Y; Volpert OV; Vande Woude GF
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12718-23. PubMed ID: 14555767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scatter factor expression and regulation in human glial tumors.
    Rosen EM; Laterra J; Joseph A; Jin L; Fuchs A; Way D; Witte M; Weinand M; Goldberg ID
    Int J Cancer; 1996 Jul; 67(2):248-55. PubMed ID: 8760595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.
    Brockmann MA; Papadimitriou A; Brandt M; Fillbrandt R; Westphal M; Lamszus K
    Clin Cancer Res; 2003 Oct; 9(12):4578-85. PubMed ID: 14555533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hepatocyte growth factor/scatter factor and c-Met in human dental papilla and fibroblasts from dental papilla.
    Kajihara T; Ohnishi T; Arakaki N; Semba I; Daikuhara Y
    Arch Oral Biol; 1999 Feb; 44(2):135-47. PubMed ID: 10206332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.
    Arrieta O; Garcia E; Guevara P; Garcia-Navarrete R; Ondarza R; Rembao D; Sotelo J
    Cancer; 2002 Jun; 94(12):3210-8. PubMed ID: 12115353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-expression of VEGF, c-Met and HGF/SF in secondary pleural tumors.
    Naim R; Tolnay E; Mueller KM; Kuhnen C
    Int J Mol Med; 2004 Nov; 14(5):787-91. PubMed ID: 15492846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET.
    Jiang WG; Grimshaw D; Martin TA; Davies G; Parr C; Watkins G; Lane J; Abounader R; Laterra J; Mansel RE
    Clin Cancer Res; 2003 Sep; 9(11):4274-81. PubMed ID: 14519655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
    Martin TA; Parr C; Davies G; Watkins G; Lane J; Matsumoto K; Nakamura T; Mansel RE; Jiang WG
    Carcinogenesis; 2003 Aug; 24(8):1317-23. PubMed ID: 12807719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins.
    Weimar IS; de Jong D; Muller EJ; Nakamura T; van Gorp JM; de Gast GC; Gerritsen WR
    Blood; 1997 Feb; 89(3):990-1000. PubMed ID: 9028331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
    Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.
    Hamasuna R; Kataoka H; Moriyama T; Itoh H; Seiki M; Koono M
    Int J Cancer; 1999 Jul; 82(2):274-81. PubMed ID: 10389763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression and regulation of expression of scatter factor/hepatocyte growth factor in prostatic carcinoma.
    Zhu X; Humphrey PA
    Urology; 2000 Dec; 56(6):1071-4. PubMed ID: 11113771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
    EXS; 1993; 65():311-28. PubMed ID: 8380739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
    Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
    Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
    Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.
    Takeuchi S; Wang W; Li Q; Yamada T; Kita K; Donev IS; Nakamura T; Matsumoto K; Shimizu E; Nishioka Y; Sone S; Nakagawa T; Uenaka T; Yano S
    Am J Pathol; 2012 Sep; 181(3):1034-43. PubMed ID: 22789825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
    Davies G; Mason MD; Martin TA; Parr C; Watkins G; Lane J; Matsumoto K; Nakamura T; Jiang WG
    Int J Cancer; 2003 Sep; 106(3):348-54. PubMed ID: 12845672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.